nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—Cerebral ischaemia—Vandetanib—thyroid cancer	0.0961	0.0961	CcSEcCtD
Carteolol—Respiratory failure—Vandetanib—thyroid cancer	0.0473	0.0473	CcSEcCtD
Carteolol—Hypoglycaemia—Vandetanib—thyroid cancer	0.0345	0.0345	CcSEcCtD
Carteolol—Bronchospasm—Vandetanib—thyroid cancer	0.0286	0.0286	CcSEcCtD
Carteolol—Depression—Vandetanib—thyroid cancer	0.0259	0.0259	CcSEcCtD
Carteolol—Conjunctivitis—Vandetanib—thyroid cancer	0.0252	0.0252	CcSEcCtD
Carteolol—Cardiac failure congestive—Sorafenib—thyroid cancer	0.0251	0.0251	CcSEcCtD
Carteolol—Sinusitis—Vandetanib—thyroid cancer	0.0244	0.0244	CcSEcCtD
Carteolol—Bradycardia—Vandetanib—thyroid cancer	0.0237	0.0237	CcSEcCtD
Carteolol—Visual impairment—Vandetanib—thyroid cancer	0.0225	0.0225	CcSEcCtD
Carteolol—Arrhythmia—Vandetanib—thyroid cancer	0.0208	0.0208	CcSEcCtD
Carteolol—Dysgeusia—Vandetanib—thyroid cancer	0.0199	0.0199	CcSEcCtD
Carteolol—Lacrimation—Epirubicin—thyroid cancer	0.0197	0.0197	CcSEcCtD
Carteolol—Vision blurred—Vandetanib—thyroid cancer	0.0191	0.0191	CcSEcCtD
Carteolol—Lacrimation—Doxorubicin—thyroid cancer	0.0182	0.0182	CcSEcCtD
Carteolol—Keratitis—Epirubicin—thyroid cancer	0.0178	0.0178	CcSEcCtD
Carteolol—Loss of consciousness—Vandetanib—thyroid cancer	0.0178	0.0178	CcSEcCtD
Carteolol—Oedema—Vandetanib—thyroid cancer	0.0166	0.0166	CcSEcCtD
Carteolol—Keratitis—Doxorubicin—thyroid cancer	0.0165	0.0165	CcSEcCtD
Carteolol—Insomnia—Vandetanib—thyroid cancer	0.015	0.015	CcSEcCtD
Carteolol—Dyspnoea—Vandetanib—thyroid cancer	0.0148	0.0148	CcSEcCtD
Carteolol—Arrhythmia—Sorafenib—thyroid cancer	0.014	0.014	CcSEcCtD
Carteolol—Dysgeusia—Sorafenib—thyroid cancer	0.0134	0.0134	CcSEcCtD
Carteolol—Lacrimation increased—Epirubicin—thyroid cancer	0.0126	0.0126	CcSEcCtD
Carteolol—Syncope—Sorafenib—thyroid cancer	0.0123	0.0123	CcSEcCtD
Carteolol—Loss of consciousness—Sorafenib—thyroid cancer	0.012	0.012	CcSEcCtD
Carteolol—Atrioventricular block—Epirubicin—thyroid cancer	0.0119	0.0119	CcSEcCtD
Carteolol—Asthenia—Vandetanib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Carteolol—Lacrimation increased—Doxorubicin—thyroid cancer	0.0116	0.0116	CcSEcCtD
Carteolol—Atrioventricular block—Doxorubicin—thyroid cancer	0.011	0.011	CcSEcCtD
Carteolol—Shock—Sorafenib—thyroid cancer	0.011	0.011	CcSEcCtD
Carteolol—Dizziness—Vandetanib—thyroid cancer	0.011	0.011	CcSEcCtD
Carteolol—Headache—Vandetanib—thyroid cancer	0.0104	0.0104	CcSEcCtD
Carteolol—Dyspnoea—Sorafenib—thyroid cancer	0.00996	0.00996	CcSEcCtD
Carteolol—Nausea—Vandetanib—thyroid cancer	0.00984	0.00984	CcSEcCtD
Carteolol—Diabetes mellitus—Epirubicin—thyroid cancer	0.00966	0.00966	CcSEcCtD
Carteolol—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00926	0.00926	CcSEcCtD
Carteolol—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00894	0.00894	CcSEcCtD
Carteolol—Hypoglycaemia—Epirubicin—thyroid cancer	0.00861	0.00861	CcSEcCtD
Carteolol—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00857	0.00857	CcSEcCtD
Carteolol—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00857	0.00857	CcSEcCtD
Carteolol—Diplopia—Epirubicin—thyroid cancer	0.0084	0.0084	CcSEcCtD
Carteolol—Hypersensitivity—Sorafenib—thyroid cancer	0.00823	0.00823	CcSEcCtD
Carteolol—Asthenia—Sorafenib—thyroid cancer	0.00802	0.00802	CcSEcCtD
Carteolol—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00796	0.00796	CcSEcCtD
Carteolol—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00793	0.00793	CcSEcCtD
Carteolol—Diplopia—Doxorubicin—thyroid cancer	0.00777	0.00777	CcSEcCtD
Carteolol—Dizziness—Sorafenib—thyroid cancer	0.00739	0.00739	CcSEcCtD
Carteolol—Headache—Sorafenib—thyroid cancer	0.007	0.007	CcSEcCtD
Carteolol—Nausea—Sorafenib—thyroid cancer	0.00664	0.00664	CcSEcCtD
Carteolol—Conjunctivitis—Epirubicin—thyroid cancer	0.00629	0.00629	CcSEcCtD
Carteolol—Sinusitis—Epirubicin—thyroid cancer	0.00607	0.00607	CcSEcCtD
Carteolol—Bradycardia—Epirubicin—thyroid cancer	0.00592	0.00592	CcSEcCtD
Carteolol—Conjunctivitis—Doxorubicin—thyroid cancer	0.00582	0.00582	CcSEcCtD
Carteolol—Sinusitis—Doxorubicin—thyroid cancer	0.00562	0.00562	CcSEcCtD
Carteolol—Visual impairment—Epirubicin—thyroid cancer	0.0056	0.0056	CcSEcCtD
Carteolol—Bradycardia—Doxorubicin—thyroid cancer	0.00547	0.00547	CcSEcCtD
Carteolol—Arrhythmia—Epirubicin—thyroid cancer	0.00519	0.00519	CcSEcCtD
Carteolol—Visual impairment—Doxorubicin—thyroid cancer	0.00518	0.00518	CcSEcCtD
Carteolol—Dysgeusia—Epirubicin—thyroid cancer	0.00495	0.00495	CcSEcCtD
Carteolol—Arrhythmia—Doxorubicin—thyroid cancer	0.0048	0.0048	CcSEcCtD
Carteolol—Vision blurred—Epirubicin—thyroid cancer	0.00477	0.00477	CcSEcCtD
Carteolol—Dysgeusia—Doxorubicin—thyroid cancer	0.00458	0.00458	CcSEcCtD
Carteolol—Syncope—Epirubicin—thyroid cancer	0.00454	0.00454	CcSEcCtD
Carteolol—Palpitations—Epirubicin—thyroid cancer	0.00447	0.00447	CcSEcCtD
Carteolol—Loss of consciousness—Epirubicin—thyroid cancer	0.00445	0.00445	CcSEcCtD
Carteolol—Vision blurred—Doxorubicin—thyroid cancer	0.00441	0.00441	CcSEcCtD
Carteolol—Syncope—Doxorubicin—thyroid cancer	0.0042	0.0042	CcSEcCtD
Carteolol—Palpitations—Doxorubicin—thyroid cancer	0.00414	0.00414	CcSEcCtD
Carteolol—Oedema—Epirubicin—thyroid cancer	0.00413	0.00413	CcSEcCtD
Carteolol—Loss of consciousness—Doxorubicin—thyroid cancer	0.00411	0.00411	CcSEcCtD
Carteolol—Shock—Epirubicin—thyroid cancer	0.00406	0.00406	CcSEcCtD
Carteolol—Hypotension—Epirubicin—thyroid cancer	0.00386	0.00386	CcSEcCtD
Carteolol—Oedema—Doxorubicin—thyroid cancer	0.00382	0.00382	CcSEcCtD
Carteolol—Shock—Doxorubicin—thyroid cancer	0.00376	0.00376	CcSEcCtD
Carteolol—Insomnia—Epirubicin—thyroid cancer	0.00373	0.00373	CcSEcCtD
Carteolol—Dyspnoea—Epirubicin—thyroid cancer	0.00368	0.00368	CcSEcCtD
Carteolol—Hypotension—Doxorubicin—thyroid cancer	0.00357	0.00357	CcSEcCtD
Carteolol—Insomnia—Doxorubicin—thyroid cancer	0.00346	0.00346	CcSEcCtD
Carteolol—Dyspnoea—Doxorubicin—thyroid cancer	0.00341	0.00341	CcSEcCtD
Carteolol—Hypersensitivity—Epirubicin—thyroid cancer	0.00304	0.00304	CcSEcCtD
Carteolol—Asthenia—Epirubicin—thyroid cancer	0.00296	0.00296	CcSEcCtD
Carteolol—Hypersensitivity—Doxorubicin—thyroid cancer	0.00281	0.00281	CcSEcCtD
Carteolol—Asthenia—Doxorubicin—thyroid cancer	0.00274	0.00274	CcSEcCtD
Carteolol—Dizziness—Epirubicin—thyroid cancer	0.00273	0.00273	CcSEcCtD
Carteolol—Headache—Epirubicin—thyroid cancer	0.00259	0.00259	CcSEcCtD
Carteolol—Dizziness—Doxorubicin—thyroid cancer	0.00253	0.00253	CcSEcCtD
Carteolol—Nausea—Epirubicin—thyroid cancer	0.00245	0.00245	CcSEcCtD
Carteolol—Headache—Doxorubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Carteolol—Nausea—Doxorubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
